Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Hair loss is caused by genetics and hormones, diagnosed through examination and biopsy, and treated with medications or surgery.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Gene mutations can cause problems in male genital development.

Adolescents with abnormal uterine bleeding often have polycystic ovarian syndrome and insulin resistance.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

New genes and pathways are important for testosterone production and male sexual development.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Baicalin may help reduce excessive male hormone levels in PCOS.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

No significant link between hair loss and iron or thyroid levels was found, but checking for deficiencies might still be useful.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.